Pre-existing interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis in solid tumors: A retrospective analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - academic.oup.com
Abstract Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over
previous cytotoxic chemotherapies in clinical trials among various tumors. Despite their …
被引用次数：6 相关文章

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - europepmc.org
Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over previous
cytotoxic chemotherapies in clinical trials among various tumors. Despite their favorable …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - go.gale.com
Background: Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over previous
cytotoxic chemotherapies in clinical trials among various tumors. Despite their favorable …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over previous
cytotoxic chemotherapies in clinical trials among various tumors. Despite their favorable …
[HTML] nih.gov

[HTML][HTML] Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over previous
cytotoxic chemotherapies in clinical trials among various tumors. Despite their favorable …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - …, 2024 - search.ebscohost.com
Abstract Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over
previous cytotoxic chemotherapies in clinical trials among various tumors. Despite their …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - …, 2024 - keio.elsevierpure.com
BACKGROUND: Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over
previous cytotoxic chemotherapies in clinical trials among various tumors. Despite their …
[HTML] oup.com

[HTML][HTML] Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2024 - academic.oup.com
Abstract Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over
previous cytotoxic chemotherapies in clinical trials among various tumors. Despite their …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - The …, 2023 - europepmc.org
Background Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over previous
cytotoxic chemotherapies in clinical trials among various tumors. Despite their favorable …

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

K Horiuchi, S Ikemura, T Sato, K Shimozaki… - …, 2024 - keio.elsevierpure.com
BACKGROUND: Immune checkpoint inhibitors (ICIs) have demonstrated efficacy over
previous cytotoxic chemotherapies in clinical trials among various tumors. Despite their …